MentionFox
Home › Who owns › Ginkgo Bioworks Holdings, Inc.
Owners, funding and legal record

Who owns Ginkgo Bioworks Holdings, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Ginkgo Bioworks Holdings, Inc.

MentionFox check on Ginkgo Bioworks Holdings, Inc.: no red flags found in 11 sources; 1 item to note (checked 15 November 2026). mentionfox.com/c/who-owns/ginkgo-bioworks

  • Note: Layoff plan disclosed Aug 2024 (filing)

New since last check: Layoff plan disclosed Aug 2024 (filing, first seen 14 November 2026).

Check Ginkgo Bioworks Holdings, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Ginkgo Bioworks Holdings, Inc.?

Ginkgo Bioworks Holdings, Inc. is a publicly traded company (NYSE: DNA). The most recent 5%+ ownership report names BlackRock holding 7.7% (Schedule 13G/A, filed 2026-07-30).

As of November 15, 2026, Ginkgo Bioworks Holdings, Inc. is a publicly traded company (NYSE: DNA); its largest reported holder is BlackRock, with 7.7% on Schedule 13G/A of July 30, 2026, then Cascade Investment, L.L.C. (7.5%). The largest insider holding is Reshma P. Shetty, a director and 10% owner, with 810,280 shares, per Form 4 of October 21, 2026 (Schedule 13G/A, July 30, 2026).

VIKING GLOBAL INVESTORS LP also filed stake reports on 27 other companies ↓

Is this your company?

About to sign with, pay or invest in Ginkgo Bioworks Holdings, Inc.? See the free Snapshot first.

Watch Ginkgo Bioworks Holdings, Inc.

Free to see. No signup.

Is Ginkgo Bioworks Holdings, Inc. a real, registered company?

Before you sign or pay

Who are Ginkgo Bioworks Holdings, Inc.'s owners and officers?

Ginkgo Bioworks Holdings, Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-07-30).

ReportHolderShare
Schedule 13G/A, 2026-07-30Blackrock, Inc.7.7%
Schedule 13G/A, 2026-05-15Viking Global Investors LP7.1%
Schedule 13G/A, 2026-03-26The Vanguard Group0%
Schedule 13G/A, 2026-02-05Baillie Gifford & Co4.9%
Schedule 13G/A, 2025-11-14Cascade Investment, L.L.C.7.5%
Schedule 13G, 2025-07-29The Vanguard Group5.13%
Schedule 13G, 2025-07-17Blackrock, Inc.6.5%

Questions about who owns Ginkgo Bioworks Holdings, Inc.

Who owns Ginkgo Bioworks Holdings, Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of Ginkgo Bioworks Holdings, Inc.: Blackrock, Inc. (7.7%, Schedule 13G/A, filed 2026-07-30), Cascade Investment, L.L.C. (7.5%, Schedule 13G/A, filed 2025-11-14) and Viking Global Investors LP (7.1%, Schedule 13G/A, filed 2026-05-15).

Who are the largest shareholders of Ginkgo Bioworks Holdings, Inc.?

By the share each holder's latest filing reports, the largest holders of Ginkgo Bioworks Holdings, Inc. on this page are Blackrock, Inc. (7.7%), Cascade Investment, L.L.C. (7.5%) and Viking Global Investors LP (7.1%).

When did Blackrock, Inc. buy into Ginkgo Bioworks Holdings, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G, filed 2025-07-17, reporting 6.5%; its latest, Schedule 13G/A filed 2026-07-30, reports 7.7%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Ginkgo Bioworks Holdings, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Ginkgo Bioworks Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Ginkgo Bioworks Holdings, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Ginkgo Bioworks Holdings, Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.

How much has Ginkgo Bioworks Holdings, Inc. raised?

Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-04-07).

Red flags found

3 exit or restructuring plans on Form 8-K (latest Form 8-K, 2024-08-08).

Keep reading

More on Ginkgo Bioworks Holdings, Inc. and the records around it.

Ginkgo Bioworks Holdings, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/ginkgo-bioworks
Last updated 2026-11-15
Who owns Ginkgo Bioworks Holdings, Inc.? Owners, funding and legal record. MentionFox, 2026-11-15. https://mentionfox.com/who-owns/ginkgo-bioworks